logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

Sichuan Road & Bridge Group (600039.SH) won a bid for a project worth 60.625 billion yuan in the fourth quarter.

date
18:52 10/01/2025
avatar
GMT Eight
Sichuan Road and Bridge (600039.SH) disclosed its major operating data for the fourth quarter of 2024, with the company winning the bid in the fourth quarter...
Sichuan Road & Bridge Group (600039.SH) disclosed its main business data for the fourth quarter of 2024. The company won a total of 221 bidding projects in the fourth quarter, with a total amount of 60.625 billion yuan.
Related Articles
China Stock
Shanghai Fosun Pharmaceutical (600196.SH): The approval to conduct Phase I clinical trials for the treatment of advanced/metastatic solid tumors with HLX97.
China Stock
Beijing Kawin Technology Share-Holding (688687.SH)'s controlling shareholder plans to reduce their holdings by no more than 3.42 million shares of the company.
HK Stock
Vitasoy International (00345) spent HK$5.0179 million on March 5 to repurchase 718,000 shares.
Shanghai Fosun Pharmaceutical (600196.SH): The approval to conduct Phase I clinical trials for the treatment of advanced/metastatic solid tumors with HLX97.
China Stock
Beijing Kawin Technology Share-Holding (688687.SH)'s controlling shareholder plans to reduce their holdings by no more than 3.42 million shares of the company.
China Stock
Vitasoy International (00345) spent HK$5.0179 million on March 5 to repurchase 718,000 shares.
HK Stock
RECOMMEND
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
icon
02/03/2026
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
icon
02/03/2026
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
icon
02/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.